Results 11 to 20 of about 5,603,984 (294)

Sugar and Type 2 diabetes [PDF]

British Medical Bulletin, 2016
Consumption of sugar, specifically sugar-sweetened beverages, has been widely held responsible by the media for the global rise in Type 2 diabetes (T2DM).Systematic reviews and dietary guidelines relating dietary sugars to T2DM.Weight gain and T2DM incidence are associated with diet and lifestyle patterns characterized by high consumptions of any ...
Lean, Michael E.J., Te Morenga, Lisa
openaire   +6 more sources

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. [PDF]

New England Journal of Medicine, 2016
Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. Methods In this double-blind trial, we randomly assigned patients with type 2 diabetes
S. Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R. Poulter, Lasse S Ravn, William M Steinberg, Mette Stockner, B. Zinman, R. Bergenstal, J. B. Buse   +14 more
semanticscholar   +3 more sources

Precision prevention in type 2 diabetes. [PDF]

BMJ Open Diabetes Res Care
Sevilla-Gonzalez M.
europepmc   +2 more sources

The genetics of type 2 diabetes [PDF]

British Journal of Clinical Pharmacology, 2001
Of the various subtypes of diabetes, type 2 diabetes has the greatest impact on health worldwide. Around 150 million people have type 2 diabetes, and the prevalence will rise by 40% by 2010 [1]. Type 2 diabetes and its complications already consume 5–10% of health budgets in many countries [2].
McCarthy, M, Menzel, S
openaire   +7 more sources

Assessment of the operative memory capacity based on endogenous evoked potentials (P300 method) without neuropsychological testing

Анналы клинической и экспериментальной неврологии, 2017
We analyzed the dependence of the operative memory (OP) capacityon P300 parameters in healthy individuals and patientswith a varying degree of memory impairments.
V. V. Gnezditskiy, A. V. Chatskaya, O. S. Korepina, O. I. Klochkova   +3 more
doaj   +1 more source

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

New England Journal of Medicine, 2019
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...
V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey   +23 more
semanticscholar   +1 more source

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Diabetes Care, 2022
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated ...
M. Davies, V. Aroda, B. Collins, R. Gabbay, Jennifer B. Green, N. Maruthur, Sylvia E. Rosas, S. Del Prato, C. Mathieu, G. Mingrone, P. Rossing, T. Tankova, A. Tsapas, J. Buse   +13 more
semanticscholar   +1 more source

Ethnic differences in adiposity and diabetes risk – insights from genetic studies [PDF]

, 2020
Type 2 diabetes is more common in non-Europeans and starts at a younger age and at lower BMI cut-offs. This review discusses the insights from genetic studies about pathophysiological mechanisms which determine risk of disease with a focus on the role of
Bell, J.D., Bell, J.D., Thomas, E.L., Thomas, E.L., Whitcher, B., Whitcher, B., Yaghootkar, H., Yaghootkar, H.   +7 more
core   +2 more sources

Chapter 29: Male sexual dysfunction in type 2 diabetes

South African Family Practice, 2018
No abstract available.
Society for Endocrinology Metabolism and Diabetes of South Africa Type 2 Diabetes Guidelines Expert Committee
doaj   +1 more source

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
BACKGROUND The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS We randomly assigned patients with type 2 diabetes who
S. Wiviott, I. Raz, M. Bonaca, Ofri Mosenzon, Eri Toda Kato, A. Cahn, Michael G. Silverman, Thomas A. Zelniker, J. Kuder, S. Murphy, Deepak L. Bhatt, Lawrence A Leiter, Darren K Mcguire, J. Wilding, C. Ruff, I. Gause-Nilsson, M. Fredriksson, P. Johansson, A. Langkilde, M. Sabatine   +19 more
semanticscholar   +1 more source